Literature DB >> 30096005

Disparities in Adolescent and Young Adult Sarcoma Survival: Analyses of the Texas Cancer Registry and the National SEER Data.

Jaqueline C Avila1, J Andrew Livingston2, Ana M Rodriguez3, Anne C Kirchhoff4, Yong-Fang Kuo1, Sapna Kaul1.   

Abstract

PURPOSE: Examine disparities in survival for adolescents and young adults (AYAs) diagnosed with bone and soft tissue sarcomas in Texas compared with national estimates.
METHODS: AYAs with sarcomas diagnosed between 1995 and 2012 at ages 15-39 years were identified from the Texas Cancer Registry (TCR) and Surveillance, Epidemiology, and End Results (SEER) program. Patient demographic, treatment, and clinical characteristics were compared between TCR and SEER using chi-squared tests. Five-year survival was computed using the Kaplan-Meier method. Cox proportional hazards (CPH) models evaluated the factors associated with the risk of mortality between and within the two datasets.
RESULTS: Sarcoma patients in TCR were more likely to be Hispanic, uninsured, diagnosed at late stage, and have lower rates of surgery as the first line of treatment than those in SEER. In Texas, 5-year survival was 68.7% versus 72.2% in SEER (p < 0.001). However, after including surgery in our fully adjusted CPH model, survival differences between the two datasets were no longer observed. In these models, males, and those living in nonmetropolitan areas were more likely to die than their counterparts in both datasets. In TCR, those who lived in the U.S. and Mexico border had higher mortality. In SEER, Hispanics and non-Hispanic blacks had higher mortality.
CONCLUSION: The adjusted AYA sarcoma survival in Texas was similar to that of SEER, but patients in Texas were more likely to be uninsured and have lower surgery rates. Those living in the U.S. and Mexico border in Texas faced lower survival. These results are important for delineating effective care for this high-risk patient group.

Entities:  

Keywords:  SEER; Texas cancer registry; sarcoma; survival analysis

Mesh:

Year:  2018        PMID: 30096005      PMCID: PMC6909766          DOI: 10.1089/jayao.2018.0034

Source DB:  PubMed          Journal:  J Adolesc Young Adult Oncol        ISSN: 2156-5333            Impact factor:   2.223


  12 in total

1.  Long-term cause-specific mortality in survivors of adolescent and young adult bone and soft tissue sarcoma: a population-based study of 28,844 patients.

Authors:  Paul Youn; Michael T Milano; Louis S Constine; Lois B Travis
Journal:  Cancer       Date:  2014-04-18       Impact factor: 6.860

2.  Overall Survival in Cancer Drug Trials as a New Surrogate End Point for Overall Survival in the Real World.

Authors:  Sham Mailankody; Vinay Prasad
Journal:  JAMA Oncol       Date:  2017-07-01       Impact factor: 31.777

3.  Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5.

Authors:  Annalisa Trama; Laura Botta; Roberto Foschi; Andrea Ferrari; Charles Stiller; Emmanuel Desandes; Milena Maria Maule; Franco Merletti; Gemma Gatta
Journal:  Lancet Oncol       Date:  2016-05-26       Impact factor: 41.316

Review 4.  Overview of sarcomas in the adolescent and young adult population.

Authors:  Cynthia E Herzog
Journal:  J Pediatr Hematol Oncol       Date:  2005-04       Impact factor: 1.289

5.  The symptom-to-diagnosis delay in soft tissue sarcoma influence the overall survival and the development of distant metastasis.

Authors:  Tomoki Nakamura; Akihiko Matsumine; Takao Matsubara; Kunihiro Asanuma; Astumasa Uchida; Akihiro Sudo
Journal:  J Surg Oncol       Date:  2011-07-08       Impact factor: 3.454

6.  Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database.

Authors:  Andrea Ferrari; Iyad Sultan; Tseng Tien Huang; Carlos Rodriguez-Galindo; Ahmad Shehadeh; Cristina Meazza; Kirsten K Ness; Michela Casanova; Sheri L Spunt
Journal:  Pediatr Blood Cancer       Date:  2011-07-25       Impact factor: 3.167

7.  Adolescent and young adult cancer survival.

Authors:  Denise Riedel Lewis; Nita L Seibel; Ashley Wilder Smith; Margaret R Stedman
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

8.  Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma.

Authors:  Steve R Martinez; Anthony S Robbins; Frederick J Meyers; Richard J Bold; Vijay P Khatri; James E Goodnight
Journal:  Cancer       Date:  2008-03-01       Impact factor: 6.860

9.  Socioeconomic, Rural-Urban, and Racial Inequalities in US Cancer Mortality: Part I-All Cancers and Lung Cancer and Part II-Colorectal, Prostate, Breast, and Cervical Cancers.

Authors:  Gopal K Singh; Shanita D Williams; Mohammad Siahpush; Aaron Mulhollen
Journal:  J Cancer Epidemiol       Date:  2012-02-14

Review 10.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

View more
  6 in total

1.  Variation in Management of Extremity Soft-Tissue Sarcoma in Younger vs Older Adults.

Authors:  Crystal Seldon; Gautam Shrivastava; Abdurrahman Al-Awady; David Asher; Stephen Ramey; Melanie Fernandez; Sarah Dooley; Deukwoo Kwon; Wei Zhao; Neha Goel; Tejan Diwanji; Ty Subhawong; Jonathan Trent; Raphael Yechieli
Journal:  JAMA Netw Open       Date:  2021-08-02

2.  Disparities in the long-term survival of adolescent and young adult diffuse large B cell lymphoma survivors.

Authors:  Amy M Berkman; Clark R Andersen; Vidya Puthenpura; J A Livingston; Sairah Ahmed; Branko Cuglievan; Michelle A T Hildebrandt; Michael E Roth
Journal:  Cancer Epidemiol       Date:  2021-09-28       Impact factor: 2.984

3.  Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results Analysis.

Authors:  Amy M Berkman; Clark R Andersen; Branko Cuglievan; David C McCall; Philip J Lupo; Susan K Parsons; Courtney D DiNardo; Nicholas J Short; Nitin Jain; Tapan M Kadia; J A Livingston; Michael E Roth
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-06-01       Impact factor: 4.090

4.  Surgical management of sarcoma in adolescent and young adult patients.

Authors:  Kazuhiko Hashimoto; Shunji Nishimura; Naohiro Oka; Masao Akagi
Journal:  BMC Res Notes       Date:  2020-05-26

5.  Impact of Race, Ethnicity, and Socioeconomic Status over Time on the Long-term Survival of Adolescent and Young Adult Hodgkin Lymphoma Survivors.

Authors:  Amy M Berkman; Clark R Andersen; Vidya Puthenpura; J Andrew Livingston; Sairah Ahmed; Branko Cuglievan; Michelle A T Hildebrandt; Michael E Roth
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-07-08       Impact factor: 4.254

6.  Clinical features and outcomes of primary bone and soft tissue sarcomas in adolescents and young adults.

Authors:  Kazuhiko Hashimoto; Shunji Nishimura; Naohiro Oka; Masao Akagi
Journal:  Mol Clin Oncol       Date:  2020-02-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.